Reports and Briefs on Pharmaceuticals

Published within

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

Type Product title / description Pub Price
Report
Report

Pharma Company Outlook to 2016

Analysis of the outlook for all of the company's covered by Datamonitor's PharmaVitae team through to 2016, identifying key strategic themes and looking at sales performance by company, lifecycle stage, therapy area, and disease

Published By Datamonitor
07 Dec 2011 $2800
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally. It includes an overview of the background behind these events and popular strategic responses.

Published By Datamonitor
08 Dec 2011 $1520
Buy
Report
Report

Biosimilars: Pipeline Trends

The report provides an overview of biosimilar and copy-biologic product landscape, split by marketed and pipeline products, target therapy areas and indications, geography, and drug developers.

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Allergan Inc.: PharmaVitae Report

Analysis of Allergan's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

US Generics Overview

Sales of generic products in the US have historically grown at an impressive rate. However, the market has now reached a turning point: while considerable scope for growth remains, the number of new brands becoming available to genericize is slowing.

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Les Laboratoires Servier: PharmaVitae Report

Analysis of Servier's corporate strategy, marketed portfolio and pipeline potential in 2010 and to 2016.

Published By Datamonitor
12 Dec 2011 $2800
Buy
Report
Report

Baxter International Inc.: PharmaVitae Report

Analysis of Baxter's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
14 Dec 2011 $2800
Buy
Report
Report

Takeda Pharmaceutical Co., Ltd: PharmaVitae Report

Analysis of Takeda's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
14 Dec 2011 $2800
Buy
Report
Report

Eisai Co., Ltd: PharmaVitae Report

Analysis of Eisai's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
14 Dec 2011 $2800
Buy
Report
Report

Emerging Pharma & Biotech Company Outlook to 2016

Analysis of the outlook for a selection of emerging pharma and biotech players through to 2016, identifying key companies, therapy areas, diseases, and molecule types.

Published By Datamonitor
14 Dec 2011 $2800
Buy

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

No help is available.